Efraim Kessous in Gaithersburg, Maryland

Medical School: Sorry, his university is not listed
Graduation Year: 2002
The Primary Medical Specialty for Efraim Kessous is listed as: Family Practice
Approximate Years of Experience: 22
PAC (PECOS ID)#: 8426180589
NPI #: 1699983858
NPI Created On: 05/20/2007
NPI Last Updated Listed as: 05/17/2023
Primary Taxonomy Code: 207Q00000X

URL not found for state: DC licensing board.
License Number:
MD040210
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Humana
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Hebrew, Hebrew, English.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Coronavirus ag ia
3. Sars-cov-2 covid-19 amp prb
4. Detection test for influenza virus
5. Vaccine for influenza for injection into muscle
6. Vaccine for influenza for administration into muscle, 0.5 ml dosage
7. New patient office or other outpatient visit, typically 30 minutes
8. New patient office or other outpatient visit, typically 45 minutes
9. New patient office or other outpatient visit, typically 60 minutes
10. Established patient office or other outpatient visit, typically 5 minutes
11. Established patient office or other outpatient visit, typically 10 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Prolonged office or other outpatient service first hour
16. Administration of influenza virus vaccine
17. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
18. Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel
19. 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r